Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT04771806
- Status
- Recruiting
Conditions
- Malignant Glioma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Magnetic Resonance Imaging — PROCEDUREUndergo MRI
- Neurocognitive Assessment — OTHERUndergo neurocognitive testing
- Quality-of-Life Assessment — OTHERAncillary studies
- Questionnaire Administration — OTHERAncillary studies
Study Details
This study examines whether repeated magnetic resonance imaging (MRI)s scan helps identify changes in the tumor during radiation and chemotherapy treatment in patients with high grade glioma. Additional MRIs scan may help researchers to see changes in the status of the disease. Seeing these changes may result in changes to the treatment plan.
Key Dates
- Start date
- Apr 1, 2019
- Status verified
- Mar 2026
- Primary completion
- Feb 2, 2027
- Completion
- Feb 2, 2027
Study Design
- Enrollment
- 80 participants (estimated)
Arms
- Arm: Observational (MRI)Patients undergo MRI with and without contrast immediately before radiotherapy (for radiation planning) and at mid treatment (week 3). Patients also undergo MRI without contrast on weeks 1, 2, 4, 5, and 6 of radiotherapy. Patients may also undergo neurocognitive function testing over 70 minutes before treatment, at the end of each week of treatment, and at 3 and 6 months after completion of treatment.
Primary Outcome Measure
Differences in the delineated target and organ at risk volumes and dosimetry [ Time Frame: Up to 2 years ]
Central Contacts
- Caroline Chung713-563-2300
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| M D Anderson Cancer Center | Houston | Texas | 77030 | Caroline Chung 713-563-2300 Caroline Chung (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By research site
Related Studies
- A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)PHASE1/PHASE2 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing SurgeryPHASE1/PHASE2 · Recruiting · Stanford University · Palo Alto, California
- Non-invasive Glioma Characterization Through Molecular ImagingRecruiting · University of Miami · Miami, Florida
- Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young AdultsPHASE1 · Recruiting · Sabine Mueller, MD, PhD · Birmingham, Alabama